Hyderabad: International Vaccine Institute (IVI) on Wednesday said Bharat Biotech's Chikungunya vaccine candidate (BBV87) was administered to first volunteer in Costa Rica during phase II/III clinical trial.This marks a multi-country study led by IVI in partnership with Bharat Biotech and funded by...